Sponsor

Alexza Pharmaceuticals, Inc.

Clinical research sponsor

Published trials9

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

9 shown

Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF EpisodesNCT05979415 · lead sponsor · 2023-09-27

TERMINATED

Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's DiseaseNCT04157933 · lead sponsor · 2019-10-16

COMPLETED

Staccato Apomorphine Single and Multi Dose PKNCT03822364 · lead sponsor · 2018-11-26

COMPLETED

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I DisorderNCT03513549 · lead sponsor · 2014-11-04

SUSPENDED

Staccato Loxapine Pulmonary Safety in Patients With COPDNCT00889837 · lead sponsor · 2009-06-01

COMPLETED

Staccato Loxapine Pulmonary Safety in Patients With AsthmaNCT00890175 · lead sponsor · 2009-05-01

COMPLETED

Staccato Loxapine in Agitated Patients With SchizophreniaNCT00628589 · lead sponsor · 2008-02-01

COMPLETED

Staccato Loxapine in Agitation (Proof of Concept)NCT00369577 · lead sponsor · 2006-08-01

COMPLETED

Staccato Loxapine Single Dose PKNCT00444028 · lead sponsor · 2005-09-01

COMPLETED

Sponsor roles

lead sponsor9

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.